ArticleMDM policy & practice

Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.

Victoria Federico Paly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.